1. Home
  2. Analysis

Guillain barre syndrome and drugs of ingredients of telmisartan (a real world drug study)


Summary:

Guillain barre syndrome is found among people who take drugs with ingredients of telmisartan, especially for people who are female, 60+ old , have been taking the drugs for 2 - 5 years. This phase IV clinical study is created by eHealthMe based on reports of 34,958 people who have side effects when taking drugs with ingredients of telmisartan from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Micardis, Telmisartan.

On Feb, 19, 2026

34,958 people reported to have side effects when taking drugs with ingredients of telmisartan.
Among them, 20 people (0.06%) have Guillain barre syndrome

What is Guillain barre syndrome?

Guillain barre syndrome (the body's immune system attacks its peripheral nervous system) is found to be associated with 478 drugs and 1,200 conditions by eHealthMe. Check the latest studies of Guillain barre syndrome.

Number of reports submitted per year:

Could drugs with ingredients of telmisartan cause Guillain barre syndrome?

Time on drugs with ingredients of telmisartan when people have Guillain barre syndrome *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Guillain barre syndrome when taking drugs with ingredients of telmisartan *:

  • female: 70 %
  • male: 30 %

Age of people who have Guillain barre syndrome when taking drugs with ingredients of telmisartan *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 47.06 %
  • 60+: 52.94 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Pain: 6 people, 30.00%
  2. Breast Cancer Metastatic: 6 people, 30.00%
  3. Insomnia (sleeplessness): 5 people, 25.00%
  4. Thyroid Diseases: 3 people, 15.00%
  5. Renal Cell Carcinoma (a kidney cancer): 3 people, 15.00%
  6. High Blood Cholesterol: 3 people, 15.00%
  7. Type 2 Diabetes: 2 people, 10.00%
  8. Non-Small Cell Lung Cancer Stage Iii: 2 people, 10.00%
  9. Diarrhea: 2 people, 10.00%
  10. Bipolar Disorder (mood disorder): 2 people, 10.00%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Percocet: 9 people, 45.00%
  2. Lapatinib: 8 people, 40.00%
  3. Paclitaxel: 7 people, 35.00%
  4. Hydrochlorothiazide: 7 people, 35.00%
  5. Restoril: 5 people, 25.00%
  6. Zometa: 5 people, 25.00%
  7. Temazepam: 4 people, 20.00%
  8. Zoledronic Acid: 4 people, 20.00%
  9. Sunitinib Malate: 3 people, 15.00%
  10. Vitamin A: 2 people, 10.00%

Other side effects people have besides Guillain barre syndrome *:

You may use this to check any potential undetected side effects.

  1. Dehydration (dryness resulting from the removal of water): 9 people, 45.00%
  2. Fatigue (feeling of tiredness): 8 people, 40.00%
  3. Hypotension (abnormally low blood pressure): 8 people, 40.00%
  4. Neuropathy Peripheral (surface nerve damage): 8 people, 40.00%
  5. Bone Pain: 8 people, 40.00%
  6. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 35.00%
  7. Fall: 3 people, 15.00%
  8. Gait Disturbance: 2 people, 10.00%
  9. Coronary Artery Stenosis (narrowing of coronary artery): 1 person, 5.00%
  10. Coordination Abnormal (abnormal movement): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of telmisartan, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.